2020 Half Year Report
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
May CARG 2020.Pdf
ISSUE 30 – MAY 2020 ISSUE 30 – MAY ISSUE 29 – FEBRUARY 2020 Promoting positive mental health in teenagers and those who support them through the provision of mental health education, resilience strategies and early intervention What we offer Calm Harm is an Clear Fear is an app to Head Ed is a library stem4 offers mental stem4’s website is app to help young help children & young of mental health health conferences a comprehensive people manage the people manage the educational videos for students, parents, and clinically urge to self-harm symptoms of anxiety for use in schools education & health informed resource professionals www.stem4.org.uk Registered Charity No 1144506 Any individuals depicted in our images are models and used solely for illustrative purposes. We all know of young people, whether employees, family or friends, who are struggling in some way with mental health issues; at ARL, we are so very pleased to support the vital work of stem4: early intervention really can make a difference to young lives. Please help in any way that you can. ADVISER RANKINGS – CORPORATE ADVISERS RANKINGS GUIDE MAY 2020 | Q2 | ISSUE 30 All rights reserved. No part of this publication may be reproduced or transmitted The Corporate Advisers Rankings Guide is available to UK subscribers at £180 per in any form or by any means (including photocopying or recording) without the annum for four updated editions, including postage and packaging. A PDF version written permission of the copyright holder except in accordance with the provision is also available at £360 + VAT. of copyright Designs and Patents Act 1988 or under the terms of a licence issued by the Copyright Licensing Agency, Barnard’s Inn, 86 Fetter Lane, London, EC4A To appear in the Rankings Guide or for subscription details, please contact us 1EN. -
March 2010 Annual Report
TR Property Investment Trust plc –TR Property Investment Trust ReportMarch 2010 & Accounts for the year ended 31 TR Property Investment Trust plc Report & Accounts for the year ended 31 March 2010 TR Property Investment Trust plc is managed by This document is printed on Revive Silk of which 75% of the furnish is made from 100% de-inked post consumer waste. The remaining 25% being mill broke and virgin fibres. This paper is bleached using a combination of Totally Chlorine Free (TCF) and Elemental Chlorine Free (ECF). The manufacturing mill is accredited with the ISO 14001 standard for environmental management. TR Property Investment Trust plc Directors’ Review Accounts 1 Overview 62 Independent Auditors’ Report 2 Statement of Investment Objective and Policy 63 Group Income Statement 4 Financial Highlights and Performance 64 Group and Company Statement of Changes in Equity 5 Historical Performance 65 Group and Company Balance Sheets 6 Chairman’s Statement 66 Group and Company Cash Flow Statements 10 Managers’ Report – Market Background and Outlook 67 Notes to the Financial Statements 15 Ordinary Shares – Financial Highlights and Performance Shareholder Information 16 Ordinary Shares – Manager’s Report 89 Notice of Annual General Meeting 21 Ordinary Shares – Portfolio Details 93 Notice of Separate Class Meeting of Ordinary 27 Ordinary Shares – Income Statement Shareholders 28 Ordinary Shares – Balance Sheet 94 Notice of Separate Class Meeting of Sigma Shareholders 29 Sigma Shares – Financial Highlights and Performance 95 Explanation of -
Jefferies 2013 Global Healthcare Conference in London
Jefferies 2013 Global Healthcare Conference in London At the 2012 Jefferies Global Healthcare Conference, there were well over 200 healthcare companies participating with a combined market cap of $1 trillion and close to 1,300 one-on-one/small group meetings over the two-day event. The 2013 conference is set to follow the same footsteps, featuring public and private leading INVITATION global healthcare companies within the areas of pharmaceuticals, biotech, generics, 20-21 NOVEMBER 2013 medtech and healthcare services from the US, Central and Eastern Europe, Latin The Waldorf Hilton America, India, China, Japan, Egypt, Israel and Russia. London, UK Throughout the two-day event, we will feature concurrent tracks of informative presentations as well as 1x1/small group meetings, and thematic panel discussions. This global gathering of institutional investors, private equity investors, VCs and leading executives will address near- and long-term investment opportunities and discuss the mechanisms driving global healthcare. We hope you can join us for what promises to be a unique and comprehensive view of the industry. Registration is now open. Please email your Jefferies representative if you are interested in attending. For general questions, please email [email protected] or contact your Jefferies representative. © 2013 Jefferies LLC. Member SIPC. AGENDA WEDNESDAY, 20 NOVEMBER 2013 Jefferies 2013 Global Healthcare Conference in London ADELPHI 1 ADELPHI 2 ADELPHI 3 EXECUTIVE BOARDROOM 7:30 AM Breakfast & Registration 8:00 AM Clinigen Group Plc Ion Beam Applications Active Biotech AB Syneron Medical Ltd. Specialty Pharma & Healthcare Services Medical Products Biotechnology Medical Technology Paul Thomas; CTO Olivier Legrain, CEO Tomas Leanderson; President and CEO Hugo Goldman, CFO 8:40 AM Valneva Celltrion, Inc. -
Blackrock UK Smaller Companies PDF Factsheet
Adventurous 31 August 2021 Life Fund SW BlackRock UK Smaller Companies Life Asset Allocation (as at 31/07/2021) This document is provided for the purpose of UK Small Cap Companies 99.8% information only. This factsheet is intended for individuals who are familiar with investment Money Market 0.2% terminology. Please contact your financial adviser if you need an explanation of the terms used. This material should not be relied upon as sufficient information to support an investment decision. The portfolio data on this factsheet is updated on a quarterly basis. Fund Aim The fund aims for long-term growth by investing in UK smaller companies which the Fund Manager considers to have above average long-term growth prospects. The fund Sector Breakdown (as at 31/07/2021) invests solely through the BlackRock UK Consumer Discretionary 27.7% Smaller Companies Unit Trust. Industrials 25.1% Basic Fund Information Financials 12.2% Fund Launch Date 19/09/2001 Technology 11.3% Fund Size £5.3m Basic Materials 5.1% Sector ABI UK Smaller Other 4.9% Companies Energy 3.8% ISIN GB0030873565 Consumer Staples 3.8% MEX ID SWMUL Health Care 3.7% SEDOL 3087356 Telecommunications 2.5% Manager Name Roland Arnold Regional Breakdown (as at 31/07/2021) Manager Since 26/03/2015 Top Ten Holdings (as at 31/07/2021) WATCHES OF SWITZERLAND 2.9% GROUP PLC IMPAX ASSET MANAGEMENT 2.4% GROUP PLC TREATT PLC 2.2% The composition of asset mix and asset allocation may change at any time and exclude cash CVS GROUP PLC 2.1% unless otherwise stated BREEDON GROUP PLC 2.0% OXFORD INSTRUMENTS PLC 1.8% INTEGRAFIN HOLDINGS PLC 1.8% AUCTION TECHNOLOGY GROUP 1.7% PLC ERGOMED PLC 1.7% LEARNING TECHNOLOGIES GROUP 1.7% PL TOTAL 20.3% Page 1 Past Performance Fund Rating Information 100% Overall Morningstar **** Rating Morningstar Analyst Rating 50% FE fundinfo Crown Rating The FE fundinfo Crown Rating relates to this fund. -
Parker Review
Ethnic Diversity Enriching Business Leadership An update report from The Parker Review Sir John Parker The Parker Review Committee 5 February 2020 Principal Sponsor Members of the Steering Committee Chair: Sir John Parker GBE, FREng Co-Chair: David Tyler Contents Members: Dr Doyin Atewologun Sanjay Bhandari Helen Mahy CBE Foreword by Sir John Parker 2 Sir Kenneth Olisa OBE Foreword by the Secretary of State 6 Trevor Phillips OBE Message from EY 8 Tom Shropshire Vision and Mission Statement 10 Yvonne Thompson CBE Professor Susan Vinnicombe CBE Current Profile of FTSE 350 Boards 14 Matthew Percival FRC/Cranfield Research on Ethnic Diversity Reporting 36 Arun Batra OBE Parker Review Recommendations 58 Bilal Raja Kirstie Wright Company Success Stories 62 Closing Word from Sir Jon Thompson 65 Observers Biographies 66 Sanu de Lima, Itiola Durojaiye, Katie Leinweber Appendix — The Directors’ Resource Toolkit 72 Department for Business, Energy & Industrial Strategy Thanks to our contributors during the year and to this report Oliver Cover Alex Diggins Neil Golborne Orla Pettigrew Sonam Patel Zaheer Ahmad MBE Rachel Sadka Simon Feeke Key advisors and contributors to this report: Simon Manterfield Dr Manjari Prashar Dr Fatima Tresh Latika Shah ® At the heart of our success lies the performance 2. Recognising the changes and growing talent of our many great companies, many of them listed pool of ethnically diverse candidates in our in the FTSE 100 and FTSE 250. There is no doubt home and overseas markets which will influence that one reason we have been able to punch recruitment patterns for years to come above our weight as a medium-sized country is the talent and inventiveness of our business leaders Whilst we have made great strides in bringing and our skilled people. -
Report & Accounts 2018
Report & Accounts 2018 Report & Accounts Derwent London plc Report & Accounts 2018 CONTENTS STRATEGIC REPORT GOVERNANCE 2018 summary ......................................................................................... 04 Introduction from the Chairman ........................................................... 84 Chairman’s statement ............................................................................ 07 Governance at a glance .......................................................................... 86 Chief Executive’s statement .................................................................. 08 Board of Directors ................................................................................... 88 CEO succession ........................................................................................11 Senior management ............................................................................... 90 London: Open for business .....................................................................12 Corporate governance statement ........................................................ 92 Central London office market ................................................................14 Nominations Committee report ......................................................... 100 A well-placed portfolio ............................................................................16 Audit Committee report ....................................................................... 104 Our stakeholders ......................................................................................18 -
EMBARGOED UNTIL 4 MARCH 2021 John Laing Group Plc Results For
EMBARGOED UNTIL 4 MARCH 2021 John Laing Group plc Results for the year ended 31 December 2020 NAV per share at 31 December 2020, before dividends paid in the year, of 320 pence, representing a 5% reduction from 31 December 2019. After challenging H1 2020, improved H2 2020 performance in-line with guidance provided at H1 results, with 5% underlying NAV growth1 in the second half driven by strong value creation in PPP & Projects and stable underlying Renewable Energy performance. With our strong balance sheet and differentiated and international greenfield platform, we are well positioned to invest in a growing and attractive infrastructure market. Governments in all of our core markets are looking to infrastructure investment to support growth and future-proof their economies, creating opportunities for John Laing in new and existing sectors. John Laing Group plc (“John Laing” or “the Group”) is today announcing its audited results for the year ended 31 December 2020. Year ended or as at Six months ended or Year ended or as at £ million (unless otherwise stated) 31 December 2020 as at 30 June 2020 31 December 2019 Net assets (“net asset value” or “NAV”) 1,529 1,525 1,658 Portfolio value 1,542 1,603 1,768 NAV per share before dividends paid1 320p 317p 347p NAV per share2 310p 309p 337p (Loss)/profit before tax (65) (95) 100 Dividend per share 9.70p 1.88p 9.50p 1 NAV per share before dividends paid at 31 December 2020 is calculated based on NAV before the 2019 final dividend of £38 million and the 2020 interim dividend of £9million, paid in May and October 2020 respectively, and equivalent to 9.5 pence per share 2 NAV per share at 31 December 2020 calculated as NAV of £1,529 million divided by the number of shares in issue at 31 December 2020 of 493.1 million, excluding shares held in the Employee Benefit Trust (“EBT”) Full year highlights: • Return to NAV growth and significant improvement in second half performance: underlying1 H2 NAV growth of 5%. -
Cboe UK Healthcare Sector Index BUKHLTH
Cboe UK Healthcare Sector Index BUKHLTH Page 1 August 2021 Cboe Exchange This sector represents products and services that are designed, developed, and utilized in the promotion of health and well-being, including medical services, health plans, medical devices, and biopharmaceuticals. The parent index is the Cboe UK All Companies (BUKAC). The index base level is 10,000 as of December 31st, 2010. This is a price return index. Objective The index is designed for use in the creation of index tracking funds, derivatives and as a performance benchmark. Investability Liquidity Transparency Availability Stocks are selected and Stocks are screened to Uses a transparent, rules-based Calculation is based on weighted to ensure that the ensure that the index is construction process. Index price and total return index is investable. tradable. Rules are freely available on the methodologies, both real cboe.com/europe/indices -time, intra-second and website. end of day. Statistics Index ISIN Ticker RIC Currency Cboe UK Healthcare Sector DE000SLA1DJ6 BUKHLTH .BUKHLTH GBP Cboe UK Healthcare Sector - net DE000SLA18F5 BUKHLTHN .BUKHLTHN GBP Volatility Volatility (1y) 0.1776 Returns(%) 1M 3M 6M YTD 1Y 3Y 5Y BUKHLTH 2.03 2.35 16.31 7.02 -2.85 13.78 17.14 BUKHLTHN 2.97 3.33 18.35 10.28 0.52 26.24 39.74 Top 5 Performers Country 1 month return % INDIVIOR PLC UNITED KINGDOM 17.70 MEDICLINIC INTERNATIONAL PLC UNITED KINGDOM 12.80 OXFORD BIOMEDICA PLC UNITED KINGDOM 11.38 PURETECH HEALTH PLC UNITED KINGDOM 8.77 VECTURA GROUP PLC UNITED KINGDOM 7.76 Historical Performance Chart 100% 80% 60% 40% 20% 0% 2011 2013 2014 2016 2017 2018 2020 2021 Cboe UK Healthcare Sector (GBP) Cboe UK All Companies (GBP) Cboe.com | ©Cboe | /CboeGlobalMarkets | /company/cboe © 2021 Cboe Exchange, Inc. -
Investec W&I – Morning Minutes 04.08.2020
Morning Meeting 4 August 2020 Index +/- % change Currencies +/- 12 month range FTSE 100 6032.9 135.1 2.3 £:$ 1.303 -0.01 1.15 1.33 FTSE All-Share 3349.5 67.5 2.1 Y:$ 106.095 0.37 102.55 112.09 DJ Industrial Average 26664.4 236.1 0.9 E:£ 1.110 0.00 1.07 1.20 S&P 500 3294.6 23.5 0.7 E:$ 1.174 -0.01 1.07 1.18 NASDAQ Composite Index 10902.8 157.5 1.5 10 Yr Bond Yld % +/- -3 months -12 months Nikkei Japan 1000 Index 1822.6 32.1 1.8 UK 0.10 0.00 0.25 0.67 Hang Seng Index 24458.1 -137.2 -0.6 US 0.56 0.02 0.64 1.86 EURO STOXX 50 (EUR) 3248.3 74.0 2.3 Germany -0.52 0.01 -0.59 -0.51 Switzerland SMI (PR) 10229.7 223.8 2.2 Price (p) +/- 12 month range France CAC 40 4875.9 92.2 1.9 Germany DAX (TR) 12647.0 333.6 0.0 Investec plc 150.85 0.35 128.8 498.0 Matrix Winners Price +/- % change Sector Winners % change Mkt Wt ITM Power PLC 259.5 18.5 7.7 FTSE All-Share / General Industrials - SEC 4.0 1.5 Lloyds Banking Group plc 27.9 1.6 6.0 FTSE All-Share / Life Insurance - SEC 3.61 1.5 Micro Focus International plc 291.9 14.8 5.3 FTSE All-Share / Forestry & Paper - SEC 3.34 0.4 Travis Perkins plc 1163.5 55.0 5.0 FTSE All-Share / Support Services - SEC 3.2 5.6 NatWest Group PLC 111.1 5.1 4.8 FTSE All-Share / Construction & Materials - SEC 3.1 1.5 Matrix Losers Price +/- % change Sector Losers % change Mkt Wt Hiscox Ltd 755.2 -26.4 -3.4 FTSE All-Share / Real Estate Investment & Services - SEC -0.3 0.4 Carnival plc 802.0 -24.6 -3.0 FTSE All-Share / Technology Hardware & Equipment - SEC -0.3 0.1 HSBC Holdings Plc 332.3 -9.95 -2.9 FTSE All-Share / Tobacco - SEC -
11 August 2020 Neighbourhood Planning Officer Horsham District
11 August 2020 Neighbourhood Planning Officer Horsham District Council Parkside Chart Way Charles Collins North Street E: [email protected] DL: +44 (0) 1483 796 837 Horsham RH12 1RL 244 - 246 High Street Guildford GU1 3JF T: +44 (0) 1483 796 800 F: +44 (0) 1483 796 801 savills.com Dear Sirs Billingshurst Neighbourhood Plan Regulation 16 Consultation Consultation Representation in relation to Land East of Billingshurst, Little Daux. Introduction 1.1 This representation is submitted to the Horsham District Council (HDC), on behalf of Bellway Homes Ltd (“Bellway”) and Crest Strategic Projects (“Crest”), in relation to the Billingshurst Neighbourhood Plan Regulation 16 Consultation. 1.2 This representation specifically relates to the key aspects of the Billingshurst Neighbourhood Plan (BNP) that are relevant to the Land East of Billingshurst, Little Daux (the Site). It follows the representation made to the previous consultation on the Regulation 14 Draft BNP, and seeks to highlight any comments or concerns to help ensure full consideration and enable the basic conditions to be met. 1.3 Significantly, it is highlighted that the summary of representations to the Regulation 14 consultation, as contained in the Consultation Statement (February 2020), does not refer to our previous correspondence with Billingshurst Parish Council (BPC) or our submitted representations made on behalf of Bellway and Crest. Clarification is therefore sought as to the reason why this representation is not acknowledged and whether the details and comments raised were in fact taken into consideration in preparing the Regulation 16 BNP. For ease of reference, the Regulation 14 Representation, dated 25 September 2019, is appended to this letter (Appendix A). -
Portfolio Holdings Listing Fidelity International Small Cap Opportunities Fund DUMMY As of June 30, 2021
Portfolio Holdings Listing Fidelity International Small Cap Opportunities Fund DUMMY as of June 30, 2021 The portfolio holdings listing (listing) provides information on a fund’s investments as of the date indicated. Top 10 holdings information (top 10 holdings) is also provided for certain equity and high income funds. The listing and top 10 holdings are not part of a fund’s annual/semiannual report or Form N-Q and have not been audited. The information provided in this listing and top 10 holdings may differ from a fund’s holdings disclosed in its annual/semiannual report and Form N-Q as follows, where applicable: With certain exceptions, the listing and top 10 holdings provide information on the direct holdings of a fund as well as a fund’s pro rata share of any securities and other investments held indirectly through investment in underlying non- money market Fidelity Central Funds. A fund’s pro rata share of the underlying holdings of any investment in high income and floating rate central funds is provided at a fund’s fiscal quarter end. For certain funds, direct holdings in high income or convertible securities are presented at a fund’s fiscal quarter end and are presented collectively for other periods. For the annual/semiannual report, a fund’s investments include trades executed through the end of the last business day of the period. This listing and the top 10 holdings include trades executed through the end of the prior business day. The listing includes any investment in derivative instruments, and excludes the value of any cash collateral held for securities on loan and a fund’s net other assets. -
Ishares FTSE 250 UCITS ETF GBP (Dist)
iShares FTSE 250 UCITS ETF GBP (Dist) MIDD August Factsheet Unless otherwise stated, Performance, Portfolio Breakdowns and Net Assets information as at: 31-Aug-2021 All other data as at 07-Sep-2021 This document is marketing material. For Investors in Switzerland. Investors should read the Key Capital at risk. All financial investments Investor Information Document and Prospectus prior to investing. involve an element of risk. Therefore, the value of your investment and the income from it will The Fund seeks to track the performance of an index composed of 250 mid cap UK companies that vary and your initial investment amount cannot rank below the FTSE 100 Index be guaranteed. KEY FACTS KEY BENEFITS Asset Class Equity Fund Base Currency GBP Exposure to broadly diversified UK companies 1 Share Class Currency GBP 2 Direct investment into 250 UK companies Fund Launch Date 26-Mar-2004 Share Class Launch Date 26-Mar-2004 3 Single country exposure Benchmark FTSE 250 Index Valor 1828018 Key Risks: Investment risk is concentrated in specific sectors, countries, currencies or companies. ISIN IE00B00FV128 Total Expense Ratio 0.40% This means the Fund is more sensitive to any localised economic, market, political or regulatory Distribution Frequency Quarterly events. The value of equities and equity-related securities can be affected by daily stock market Domicile Ireland movements. Other influential factors include political, economic news, company earnings and Methodology Optimised significant corporate events. Counterparty Risk: The insolvency of any institutions providing Product Structure Physical services such as safekeeping of assets or acting as counterparty to derivatives or other Rebalance Frequency Quarterly instruments, may expose the Fund to financial loss.